Ara
Toplam kayıt 2, listelenen: 1-2
Long Term Azithromycin Therapy in Patients with Cystic Fibrosis
(Turkish J Pediatrics, 2016)
Inflammation is a central contributor to the pathogenesis of cystic fibrosis (CF) pulmonary disease; so limiting the excessive production of inflammatory mediators represents a major therapeutic strategy for slowing the ...